GL Pharm Tech Corp.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

Website

www.glpt.co.kr

Country

South Korea

Exchange

KOSDAQ

Founded 2002Seongnam-si, South Korea

GL Pharm Tech provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications

Generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and areas. Additionally, it engages in developing new molecule entity pipeline products for dry eye disease Cabalin CR extended-release tablet and Jample Ibufen syrup for the nervous system and sensory organs.

Its portfolio also includes Gisoren tablets for individual organs, digestive system, and peptic ulcer drugs, and Genstring Troki for treating individual organs and digestive system oral use. Founded in 2002, GL Pharm Tech is headquartered in Seongnam-si, South Korea.

Key Stats

52-Week Range

₩778.00₩1330.00

Beta0.42

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.